AN2 Therapeutics (ANTX) investor relations material

Voting matters and shareholder proposals

• Election of three Class I directors to serve until the 2029 annual meeting or until successors are appointed.

• Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Proxy holders authorized to vote on other business properly brought before the meeting or any adjournments.

Board of directors and corporate governance

• Board recommends voting "FOR" all director nominees and the auditor ratification proposal.

• Nominees for Class I directors are Kabeer Aziz, Gilbert Lynn Marks, M.D., and Rob Readnour, Ph.D.

Audit committee and external auditor matters

• Proposal to ratify PricewaterhouseCoopers LLP as the external auditor for the upcoming fiscal year.